Home > Insider Trading > Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc. (SUPN)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q1 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to Supernus Pharmaceuticals First Quarter 2023 Financial Results Conference Call. At this time all participants are in a listen-only mode.

Keep Reading →

May 10th, 2023 - News Transcripts

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2022 Earnings Call Transcript

Operator: Good afternoon, and welcome to Supernus Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time all participants are in a listen-only mode.

Keep Reading →

March 2nd, 2023 - News Transcripts

Here's Why Supernus Pharmaceuticals (SUPN) Outperformed in Q3

Scout Investments, an affiliate of Carillon Tower Advisers, an investment management company, released its “Carillon Scout Small Cap Fund” third quarter 2022 investor letter.

Keep Reading →

January 3rd, 2023 - Hedge Fund Investor Letters News

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2022 Earnings Call Transcript

Operator: Good afternoon and welcome to Supernus Pharmaceuticals' Third Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

December 30th, 2022 - News Transcripts

5 Best Small-Cap Healthcare Stocks To Buy Now

Supernus Pharmaceuticals, Inc.

Keep Reading →

December 12th, 2022 - Hedge Funds News

5 Best Pharmaceutical Stocks to Buy According to Steven Boyd's Armistice Capital

In this article, we will take a look at some important pharma stock picks of Steven Boyd's Armistice Capital.

Keep Reading →

October 7th, 2022 - Hedge Funds News

Here's Why Third Avenue Management Invested in Supernus Pharmaceuticals (SUPN)

Third Avenue Management, an investment management company, released its “Small-Cap Value Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here.

Keep Reading →

September 23rd, 2022 - Hedge Fund Investor Letters News

Should You Consider Investing in Supernus Pharmaceuticals (SUPN)?

WertArt Capital, an investment management firm, published its second-quarter 2021 investor letter – a copy of which can be downloaded here.

Keep Reading →

August 18th, 2021 - Hedge Fund Investor Letters News

10 Cheap Healthcare Stocks To Buy Now

In this article we discuss 10 cheap healthcare stocks to buy now.

Keep Reading →

February 4th, 2021 - Hedge Funds News

Is Supernus Pharmaceuticals Inc (SUPN) A Good Stock To Buy?

The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC.

Keep Reading →

October 13th, 2020 - Hedge Funds News